Status
Conditions
Treatments
About
Populations in precarious situations or with low socio-economic status have an increased risk of diabetes and accelerated aging. According to the population studied, the elements that can explain these health inequalities are not unequivocal and remain poorly known.
The north of France, particularly affected by socio-economic disparities, has a prevalence of diabetes among the highest in metropolitan France. This is why investigators want to study the clinical, biological, social and behavioural risk factors of the entry into diabetes and accelerated aging among a large population in the North of France.
This study aims to characterize the population (among which a majority (55%) suffers from precarious conditions) who come to carry out their health examination at the Pasteur Institute in Lille in order to study the risk factors to better explain these health inequalities.
This research consists of a main descriptive observational, cross-sectional study carried out on 2233 volunteers (main group) over 18 months, and a complementary analytical case-control study that will be offered to 216 participants (sub-group).
Full description
Primary Objective : Assessment of Prevalence of Prediabetes and Diabetes by Socio-Economic Status
Primary efficacy endpoint : Fasting glucose value based on EPICES score :
Glycemia:
EPICES score: quintiles of score distribution (Q1 to Q5)
Secondary Objectives specific to the main group:
Secondary Objectives specific to the sub-group:
Secondary endpoints specific to the main group: :
Prevalence ratio of diabetes and prediabetes calculated for:
Assessment of the level of ageing
Prevalence ratio of (pre)diabetes and accelerated aging according to socio-economic status
Secondary endpoints specific to the subgroup:
Risk (OR) of (pre)diabetes and accelerated aging according to social, economic, cultural and marital status
Evaluation of (pre)diabetes: fasting blood sugar
Accelerated Aging Assessment: DNAmPhenoAge
Socio-economic and cultural criteria
Risk (OR) of (pre)diabetes and accelerated aging for assessed exposures:
Evaluation of (pre)diabetes: fasting blood sugar
Accelerated Aging Assessment: DNAmPhenoAge
Exposure Assessment
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
2,014 participants in 2 patient groups
Loading...
Central trial contact
Jean-Michel Dr LECERF, MD; Antonia Dr GASCH-ILLESCAS, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal